Dale Dougherty of MAKE magazine is joined by Tom Kalil of the White House, Francisco, D'Souza of Cognizant and Margaret Honey of the NYSCI for this conversation on the role of making in education and innovation.
About the Makers
Dale Dougherty
Founding Editor and Publisher
Make Magazine & Maker Faire
O'Reilly Media
Francisco D'Souza
Chief Executive Officer, Cognizant and Board Member, New York Hall of Science
Margaret Honey
CEO of New York Hall of Science
Tom Kalil
Deputy Director, Whitehouse Office of Science & Technology Policy
Bio
Francisco D'Souza
Francisco D'Souza is President and CEO of Cognizant Technology.
Dale Dougherty
Dale Dougherty is the editor and publisher of MAKE, and general manager of the Maker Media division of O'Reilly Media, Inc. Dale has been instrumental in many of O'Reilly's most important efforts, including founding O'Reilly Media, Inc. with Tim O'Reilly. He was the developer and publisher of Global Network Navigator (GNN), the first commercial Web site which launched in 1993 and was sold to AOL in 1995.
Dale was developer and publisher of Web Review, the online magazine for Web designers, and he was O'Reilly's first editor. Prior to developing MAKE, Dale was publisher of the O'Reilly Network and he developed the Hacks series of books. Dale is the author of "Sed & Awk." Dougherty was a Lecturer in the School of Information Management and Systems (SIMS) at the University of California at Berkeley from 1996 to 2000.
Margaret Honey
Margaret Honey is the CEO of the New York Hall of Science.
Tom Kalil
Thomas
Kalil is currently the Special Assistant to the Chancellor for Science
and Technology at UC Berkeley. He has been charged with developing
major new multi-disciplinary research and education initiatives at the
intersection of information technology, nanotechnology, microsystems,
and biology. He will also help develop a broad range of partnerships
between 2 of the California Institutes of Science and Innovation (Center
for Information Technology Research in the Interest of Society,
California Institute for Bioengineering, Biotechnology and Quantitative
Biomedical Research) and potential stakeholders in industry, government,
foundations, and non-profits.